23andMe Agrees To Sale, Rite Aid Pharmacy Deals Get OK
By Alex Wittenberg · May 27, 2025, 8:48 PM EDT
Regeneron Pharmaceuticals emerged as the winning bidder for 23andMe last week, agreeing to buy the genetics testing company out of bankruptcy for $256 million. Meanwhile, a judge approved Rite Aid's sale...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login